| Prohealth Partners, A Medical Group | |
|
3650 E. South St., Suite 212 Lakewood CA 90712 | |
| (562) 299-5200 | |
| Not Available |
| Full Name | Prohealth Partners, A Medical Group |
|---|---|
| Speciality | Internal Medicine |
| Location | 3650 E. South St., Suite 212, Lakewood, California |
| Authorized Official Name and Position | Barry Allswang (PRESIDENT) |
| Authorized Official Contact | 5622995200 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Prohealth Partners, A Medical Group 3650 E. South St., Suite 212 Lakewood CA 90712 Ph: () - | Prohealth Partners, A Medical Group 3650 E. South St., Suite 212 Lakewood CA 90712 Ph: (562) 299-5200 |
| NPI Number | 1003949975 |
|---|---|
| Provider Enumeration Date | 03/13/2007 |
| Last Update Date | 09/13/2023 |
| Medicare PECOS PAC ID | 2769388412 |
|---|---|
| Medicare Enrollment ID | O20031211000927 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003949975 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (* (Not Available)) | Primary |
| 208M00000X | Hospitalist | (* (Not Available)) | Secondary |
| Provider Name | Alan T Turner |
|---|---|
| Provider Type | Practitioner - Diagnostic Radiology |
| Provider Identifiers | NPI Number: 1659372241 PECOS PAC ID: 9335046994 Enrollment ID: I20031212000868 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Mohamed H El-gabalawy |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1407967631 PECOS PAC ID: 5698676120 Enrollment ID: I20040117000156 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Christine M Betzold |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1942284906 PECOS PAC ID: 0143113647 Enrollment ID: I20040206000962 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Jose L Pantoja |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1891721353 PECOS PAC ID: 5294629705 Enrollment ID: I20040213000229 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Michelle H Reddy |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1063477891 PECOS PAC ID: 1456246495 Enrollment ID: I20040218000499 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Nathaniel Neal |
|---|---|
| Provider Type | Practitioner - Rheumatology |
| Provider Identifiers | NPI Number: 1720006729 PECOS PAC ID: 5890681951 Enrollment ID: I20040225000680 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Catherine S Mao |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1073567236 PECOS PAC ID: 9234027434 Enrollment ID: I20040309000751 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Ali M Etemadian |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1316041718 PECOS PAC ID: 5294625448 Enrollment ID: I20040319000377 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Kay E Elledge |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1023055928 PECOS PAC ID: 4385533744 Enrollment ID: I20040325001023 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Amer R Zarka |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1629096664 PECOS PAC ID: 1355233305 Enrollment ID: I20040325001458 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Ashraf Mohamed Elmashat |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1851322887 PECOS PAC ID: 6103810692 Enrollment ID: I20040408000800 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Marcia A Senteno |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1770502650 PECOS PAC ID: 0446234199 Enrollment ID: I20040617001711 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Steven H Reynolds |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1700893294 PECOS PAC ID: 1254303076 Enrollment ID: I20040811000597 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Jesse J Licuanan |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1396795514 PECOS PAC ID: 3678547601 Enrollment ID: I20040824001319 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Gregory M Eckel |
|---|---|
| Provider Type | Practitioner - Diagnostic Radiology |
| Provider Identifiers | NPI Number: 1053383505 PECOS PAC ID: 5496721888 Enrollment ID: I20040907001372 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Michelle D Pratt |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1174541171 PECOS PAC ID: 1355304601 Enrollment ID: I20041108000477 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Hector Castillo |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1659366136 PECOS PAC ID: 4688645104 Enrollment ID: I20041117001272 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Meiling L Yuen |
|---|---|
| Provider Type | Practitioner - Dermatology |
| Provider Identifiers | NPI Number: 1386687929 PECOS PAC ID: 5991754277 Enrollment ID: I20050113000257 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Stephanie S Green |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1427062462 PECOS PAC ID: 5395795199 Enrollment ID: I20050128000952 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Robert M Sinow |
|---|---|
| Provider Type | Practitioner - Diagnostic Radiology |
| Provider Identifiers | NPI Number: 1396797080 PECOS PAC ID: 8123073608 Enrollment ID: I20050317000421 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Archna Chaudhary |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1548372634 PECOS PAC ID: 8729025606 Enrollment ID: I20050412001010 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Melvin L Seard |
|---|---|
| Provider Type | Practitioner - Urology |
| Provider Identifiers | NPI Number: 1538163126 PECOS PAC ID: 1557308483 Enrollment ID: I20050412001516 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Duke Ahn |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1942318373 PECOS PAC ID: 5698713626 Enrollment ID: I20050420001017 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Modupe Abimbola Aiyegbusi |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1710088349 PECOS PAC ID: 9335053214 Enrollment ID: I20050429000597 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Azhar Majeed |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1295802155 PECOS PAC ID: 7214979459 Enrollment ID: I20050526000889 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Juan A Silva |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1790738110 PECOS PAC ID: 8921041013 Enrollment ID: I20050609000489 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Li Li Tong |
|---|---|
| Provider Type | Practitioner - Nephrology |
| Provider Identifiers | NPI Number: 1316034192 PECOS PAC ID: 6800822321 Enrollment ID: I20050714001110 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Roger D Duber |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1942261904 PECOS PAC ID: 8022046325 Enrollment ID: I20050728000599 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | George R Espinoza |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1659451011 PECOS PAC ID: 9537197264 Enrollment ID: I20050802001406 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Jocelyn B Craig |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1104851443 PECOS PAC ID: 3870522402 Enrollment ID: I20050804000462 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Matthew J Budoff |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1811967433 PECOS PAC ID: 7810946407 Enrollment ID: I20050822000682 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Arvind J Mehta |
|---|---|
| Provider Type | Practitioner - Nephrology |
| Provider Identifiers | NPI Number: 1518985613 PECOS PAC ID: 0840218459 Enrollment ID: I20051102000759 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Alyssa T Watanabe |
|---|---|
| Provider Type | Practitioner - Diagnostic Radiology |
| Provider Identifiers | NPI Number: 1780660472 PECOS PAC ID: 7911801840 Enrollment ID: I20051109001169 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Dedra A Beckles |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1821011339 PECOS PAC ID: 3577577808 Enrollment ID: I20060125001022 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Seema A Hanamsagar |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1952387581 PECOS PAC ID: 1759395080 Enrollment ID: I20060125001032 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Vincent D Nguyen |
|---|---|
| Provider Type | Practitioner - Hospice/palliative Care |
| Provider Identifiers | NPI Number: 1073603361 PECOS PAC ID: 9931114386 Enrollment ID: I20060222000811 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Isaac Eisenstein |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1780649830 PECOS PAC ID: 1759354087 Enrollment ID: I20060403000271 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Conrad Anthony Cox |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1851338941 PECOS PAC ID: 5294746731 Enrollment ID: I20060511000258 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Peter P Ferrera |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1366481384 PECOS PAC ID: 6204830623 Enrollment ID: I20060826000095 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Roger M Samawi |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1275570822 PECOS PAC ID: 6204831142 Enrollment ID: I20060927000171 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Mohsen Badri |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1669570495 PECOS PAC ID: 0143227199 Enrollment ID: I20061103000466 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | James A Murray |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1609800044 PECOS PAC ID: 7911904792 Enrollment ID: I20061109000203 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Michael B Strauss |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1700837457 PECOS PAC ID: 2668472549 Enrollment ID: I20061226000198 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Reza Rasouli |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1053395731 PECOS PAC ID: 0941246359 Enrollment ID: I20070515000494 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | James A Jengo |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1245324201 PECOS PAC ID: 1153216858 Enrollment ID: I20070615000646 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Bahman Chavoshan |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1255480661 PECOS PAC ID: 7214024165 Enrollment ID: I20071024000710 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Fariba Javadi |
|---|---|
| Provider Type | Practitioner - Other (physician) |
| Provider Identifiers | NPI Number: 1538265830 PECOS PAC ID: 2860416583 Enrollment ID: I20071116000558 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Vannarith So |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1659416584 PECOS PAC ID: 5395833560 Enrollment ID: I20071121000594 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | David T Shen |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1235100330 PECOS PAC ID: 0345330346 Enrollment ID: I20071213000886 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Neha H Bhansali |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1700923893 PECOS PAC ID: 5890878417 Enrollment ID: I20080205000669 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Ramanath B Dukkipati |
|---|---|
| Provider Type | Practitioner - Nephrology |
| Provider Identifiers | NPI Number: 1457570376 PECOS PAC ID: 0547330656 Enrollment ID: I20080602000373 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | William L Madrid |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1467419366 PECOS PAC ID: 2567532393 Enrollment ID: I20080604000749 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Byung Don Ahn |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1194715193 PECOS PAC ID: 1153216197 Enrollment ID: I20080717000193 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Daniel Matemotja |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1821002759 PECOS PAC ID: 4183784408 Enrollment ID: I20081117000551 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Andrew G Gianoukakis |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1023083086 PECOS PAC ID: 5395805949 Enrollment ID: I20081128000065 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Sandra G Avila |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1396939575 PECOS PAC ID: 0345301792 Enrollment ID: I20081204000377 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Anuja P Shah |
|---|---|
| Provider Type | Practitioner - Nephrology |
| Provider Identifiers | NPI Number: 1851414569 PECOS PAC ID: 7113080458 Enrollment ID: I20090113000048 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Robert G Bota |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1407990773 PECOS PAC ID: 8527086297 Enrollment ID: I20090210000069 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Valentina R Dalili-shoaie |
|---|---|
| Provider Type | Practitioner - Medical Genetics And Genomics |
| Provider Identifiers | NPI Number: 1447224126 PECOS PAC ID: 8325046022 Enrollment ID: I20090227000200 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Sharon G Adler |
|---|---|
| Provider Type | Practitioner - Nephrology |
| Provider Identifiers | NPI Number: 1467431122 PECOS PAC ID: 4688730302 Enrollment ID: I20090304000789 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Stefan Schneider |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1104849108 PECOS PAC ID: 9234288937 Enrollment ID: I20090529000366 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | William W Stringer |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1487633111 PECOS PAC ID: 0244135101 Enrollment ID: I20090804000352 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Timothy C Simmons |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1124199427 PECOS PAC ID: 6103974092 Enrollment ID: I20090822000111 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Gimha S Gunawardana |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1720274921 PECOS PAC ID: 6103971965 Enrollment ID: I20090831000143 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Anthony Zamudio |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1912061391 PECOS PAC ID: 1153477104 Enrollment ID: I20090916000769 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Milan G Rawal |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1093913147 PECOS PAC ID: 7810043775 Enrollment ID: I20090917000205 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Azin Shahryarinejad |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1114187556 PECOS PAC ID: 1355487539 Enrollment ID: I20090930000710 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Yvonne Tyson |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1881617868 PECOS PAC ID: 6103963525 Enrollment ID: I20091016000261 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Ignacio M Carrillo-nunez |
|---|---|
| Provider Type | Practitioner - Neurology |
| Provider Identifiers | NPI Number: 1205827201 PECOS PAC ID: 8921146937 Enrollment ID: I20091112000122 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Kyaw Moe |
|---|---|
| Provider Type | Practitioner - Nephrology |
| Provider Identifiers | NPI Number: 1083649735 PECOS PAC ID: 5193721876 Enrollment ID: I20100128000779 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Karen T Dix |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1811920424 PECOS PAC ID: 4082757257 Enrollment ID: I20100210000454 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Rodolfo Ibarra |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1376566323 PECOS PAC ID: 5698818870 Enrollment ID: I20100210000500 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Petra Ann Wong |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1578585915 PECOS PAC ID: 1355422056 Enrollment ID: I20100215000613 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Olga R Ginzburg |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1891723482 PECOS PAC ID: 8921142795 Enrollment ID: I20100217000208 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Cherie R Garcia |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1497786396 PECOS PAC ID: 1456495233 Enrollment ID: I20100217000233 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Winston Chung |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1851322085 PECOS PAC ID: 9931244027 Enrollment ID: I20100301000289 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | John G Issa |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1043233976 PECOS PAC ID: 0648315754 Enrollment ID: I20100301000438 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Steven J Lake |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1669494001 PECOS PAC ID: 4486799145 Enrollment ID: I20100305000088 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Robert J Comer |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1134233158 PECOS PAC ID: 5193860864 Enrollment ID: I20100305000117 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Mansoor S Shah |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1962433706 PECOS PAC ID: 0446331144 Enrollment ID: I20100305000165 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Vinita Chaudhary |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1386679504 PECOS PAC ID: 5395880074 Enrollment ID: I20100305000218 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Diana R Bryant |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1255425146 PECOS PAC ID: 3971648650 Enrollment ID: I20100305000289 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Khalid Saeed |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1114958956 PECOS PAC ID: 3779628458 Enrollment ID: I20100305000306 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Dennis L Clark |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1699700849 PECOS PAC ID: 0446395131 Enrollment ID: I20100305000383 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Aaron Kern |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1891726725 PECOS PAC ID: 8820133523 Enrollment ID: I20100305000456 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Scott A Gordon |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1033140801 PECOS PAC ID: 5991840605 Enrollment ID: I20100305000599 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Michael N Castro |
|---|---|
| Provider Type | Practitioner - Dermatology |
| Provider Identifiers | NPI Number: 1437180320 PECOS PAC ID: 8628096724 Enrollment ID: I20100305000663 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | James W Norcross |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1851305809 PECOS PAC ID: 4789729310 Enrollment ID: I20100305000852 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Ivette Stickelmaier |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1962430579 PECOS PAC ID: 2860537420 Enrollment ID: I20100308000018 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Donna Alane Richey |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1841212289 PECOS PAC ID: 7012943780 Enrollment ID: I20100311000088 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Gerald A Cohen |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1306877253 PECOS PAC ID: 8224163456 Enrollment ID: I20100312000925 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Pedro De La Rosa |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1114940145 PECOS PAC ID: 0648307348 Enrollment ID: I20100429000470 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Clayton Dejong |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1467466409 PECOS PAC ID: 3072694777 Enrollment ID: I20100504000466 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Thomas Kellar Mccloy |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1568476513 PECOS PAC ID: 7517095037 Enrollment ID: I20100504000552 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Jennifer A Kim Loomis |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1215136940 PECOS PAC ID: 2062543986 Enrollment ID: I20100621000849 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Mark M Reynolds |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1831124577 PECOS PAC ID: 5698806156 Enrollment ID: I20100626000509 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Abha Gupta |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1336140458 PECOS PAC ID: 2567588064 Enrollment ID: I20100921001452 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Karen E Koe |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1780648709 PECOS PAC ID: 9931394434 Enrollment ID: I20101110000383 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Rebecca Jennie Schwartz |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1619931599 PECOS PAC ID: 2668667890 Enrollment ID: I20101112000537 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Hammad Khan |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1992904395 PECOS PAC ID: 8426243619 Enrollment ID: I20101113000029 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Viktor E Eysselein |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1609848191 PECOS PAC ID: 9436345188 Enrollment ID: I20101122000164 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Ronald J Oudiz |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1316957228 PECOS PAC ID: 3476749821 Enrollment ID: I20101124000177 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Nancy F Godfrey |
|---|---|
| Provider Type | Practitioner - Rheumatology |
| Provider Identifiers | NPI Number: 1790777449 PECOS PAC ID: 0446446819 Enrollment ID: I20101124000372 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Ronald S Swerdloff |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1104935253 PECOS PAC ID: 8426245226 Enrollment ID: I20101206000923 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Rodney A White |
|---|---|
| Provider Type | Practitioner - Vascular Surgery |
| Provider Identifiers | NPI Number: 1548316185 PECOS PAC ID: 0446447536 Enrollment ID: I20101215000883 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Lisa Anne Fisher |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1285665810 PECOS PAC ID: 8325236045 Enrollment ID: I20101222000543 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Rasam M Hosseinian |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1326092834 PECOS PAC ID: 9638107659 Enrollment ID: I20101222000652 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Barton H Ueki |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1043219355 PECOS PAC ID: 7012105315 Enrollment ID: I20110103000139 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Armaity V Austin |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1558348946 PECOS PAC ID: 4082606405 Enrollment ID: I20110104000122 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Claudia Eppele |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1285892109 PECOS PAC ID: 5890974992 Enrollment ID: I20110121000098 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Kathy E Sietsema |
|---|---|
| Provider Type | Practitioner - Critical Care (intensivists) |
| Provider Identifiers | NPI Number: 1053322032 PECOS PAC ID: 4789863762 Enrollment ID: I20110124000059 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Kamyar Zadeh Kalantar |
|---|---|
| Provider Type | Practitioner - Nephrology |
| Provider Identifiers | NPI Number: 1457314684 PECOS PAC ID: 8224218672 Enrollment ID: I20110202000479 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Duncan Q Mcbride |
|---|---|
| Provider Type | Practitioner - Neurosurgery |
| Provider Identifiers | NPI Number: 1700828704 PECOS PAC ID: 1254511629 Enrollment ID: I20110202000834 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Gregory R Mason |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1841247145 PECOS PAC ID: 5890976336 Enrollment ID: I20110216001093 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Jaime Landman |
|---|---|
| Provider Type | Practitioner - Urology |
| Provider Identifiers | NPI Number: 1437268505 PECOS PAC ID: 9638110729 Enrollment ID: I20110221000378 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Gamal M Ghoniem |
|---|---|
| Provider Type | Practitioner - Urology |
| Provider Identifiers | NPI Number: 1467415919 PECOS PAC ID: 4183754302 Enrollment ID: I20110719000015 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Nalin Mallik |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1457667495 PECOS PAC ID: 8527239367 Enrollment ID: I20110927000537 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Padmini Shamasundara |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1861478521 PECOS PAC ID: 2466625405 Enrollment ID: I20111107000805 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Seper Dezfoli |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1104159383 PECOS PAC ID: 1658545264 Enrollment ID: I20111116000856 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Edward Green |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1467554220 PECOS PAC ID: 8022160092 Enrollment ID: I20111128000698 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Lilly M Barba |
|---|---|
| Provider Type | Practitioner - Nephrology |
| Provider Identifiers | NPI Number: 1407835978 PECOS PAC ID: 4880869809 Enrollment ID: I20111202000266 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Rebekah Adia Neal |
|---|---|
| Provider Type | Practitioner - Rheumatology |
| Provider Identifiers | NPI Number: 1215165667 PECOS PAC ID: 0446427058 Enrollment ID: I20120123000812 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Edward M Uchio |
|---|---|
| Provider Type | Practitioner - Urology |
| Provider Identifiers | NPI Number: 1588648570 PECOS PAC ID: 7012045768 Enrollment ID: I20120208000201 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Mauricio J Heilbron |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1386732915 PECOS PAC ID: 6800056656 Enrollment ID: I20120402000281 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Tess Ventura |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1669782280 PECOS PAC ID: 1052574779 Enrollment ID: I20120516000599 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Rosalind C Moran |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1053511014 PECOS PAC ID: 5092978692 Enrollment ID: I20120517000627 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Sapna Singh Patel |
|---|---|
| Provider Type | Practitioner - Medical Oncology |
| Provider Identifiers | NPI Number: 1710140561 PECOS PAC ID: 6103089222 Enrollment ID: I20120529000383 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Naser M Elbalalesy |
|---|---|
| Provider Type | Practitioner - Neurology |
| Provider Identifiers | NPI Number: 1720178817 PECOS PAC ID: 0648444943 Enrollment ID: I20120702000054 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Tiane Dai |
|---|---|
| Provider Type | Practitioner - Nephrology |
| Provider Identifiers | NPI Number: 1457643751 PECOS PAC ID: 4284899824 Enrollment ID: I20120703000586 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Lindsay A Larson |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1851618151 PECOS PAC ID: 6002062734 Enrollment ID: I20120810000609 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Bhavik V Thakkar |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1033178819 PECOS PAC ID: 1254362940 Enrollment ID: I20120820000270 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Henry Su |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1902033913 PECOS PAC ID: 8022265818 Enrollment ID: I20120830000098 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | James E Sheppard |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1255686044 PECOS PAC ID: 1951558642 Enrollment ID: I20120831000411 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Meenakshi Verma |
|---|---|
| Provider Type | Practitioner - Nephrology |
| Provider Identifiers | NPI Number: 1942463427 PECOS PAC ID: 2668621137 Enrollment ID: I20120927000725 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Sam Zeim |
|---|---|
| Provider Type | Practitioner - Diagnostic Radiology |
| Provider Identifiers | NPI Number: 1558631655 PECOS PAC ID: 4284883604 Enrollment ID: I20120928000512 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Farah H Mahmood |
|---|---|
| Provider Type | Practitioner - Rheumatology |
| Provider Identifiers | NPI Number: 1134385974 PECOS PAC ID: 1153469820 Enrollment ID: I20121003000570 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Eiman Naguib |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1912211178 PECOS PAC ID: 0042468449 Enrollment ID: I20121026000637 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Babak M Goldman |
|---|---|
| Provider Type | Practitioner - Hospice/palliative Care |
| Provider Identifiers | NPI Number: 1750542445 PECOS PAC ID: 4587815253 Enrollment ID: I20121107000184 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Kristin K Kwong |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1275616393 PECOS PAC ID: 5991958977 Enrollment ID: I20121228000028 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Antony Macido |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1164766648 PECOS PAC ID: 8527211945 Enrollment ID: I20130116000153 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Rajiv T Philip |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1063601045 PECOS PAC ID: 4082859830 Enrollment ID: I20130326000499 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Venu Divi |
|---|---|
| Provider Type | Practitioner - Otolaryngology |
| Provider Identifiers | NPI Number: 1245390228 PECOS PAC ID: 9537268826 Enrollment ID: I20130424000977 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Mansurur R Khan |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1326196312 PECOS PAC ID: 1557348141 Enrollment ID: I20130507000044 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Kanchana R Viswanathan |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1760491104 PECOS PAC ID: 9436227550 Enrollment ID: I20130509000444 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Mahdi Yazdany |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1316109911 PECOS PAC ID: 0345419909 Enrollment ID: I20130820000545 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Naftoli H Weingarten |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1518205012 PECOS PAC ID: 9133362692 Enrollment ID: I20130830000698 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Sherif Y Labatia |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1619165115 PECOS PAC ID: 6103906029 Enrollment ID: I20131008000076 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Mark Jordan |
|---|---|
| Provider Type | Practitioner - Urology |
| Provider Identifiers | NPI Number: 1831121607 PECOS PAC ID: 0446242127 Enrollment ID: I20140108001650 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Sima Fargahi |
|---|---|
| Provider Type | Practitioner - Pathology |
| Provider Identifiers | NPI Number: 1124239397 PECOS PAC ID: 1951533116 Enrollment ID: I20140422002039 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Jenny Shen |
|---|---|
| Provider Type | Practitioner - Nephrology |
| Provider Identifiers | NPI Number: 1194963199 PECOS PAC ID: 7911120332 Enrollment ID: I20140603000775 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Marianne Mikhail |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1164743464 PECOS PAC ID: 4880819093 Enrollment ID: I20140702000442 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Ngoc Tram G Tran |
|---|---|
| Provider Type | Practitioner - Nephrology |
| Provider Identifiers | NPI Number: 1003052739 PECOS PAC ID: 3678799483 Enrollment ID: I20140730001868 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Frances Abigail Malantic |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1780018960 PECOS PAC ID: 5799902383 Enrollment ID: I20140805001355 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Vimal J Ponnezhan |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1366653354 PECOS PAC ID: 0941348254 Enrollment ID: I20140806002731 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Ivan A Soto-arape |
|---|---|
| Provider Type | Practitioner - Critical Care (intensivists) |
| Provider Identifiers | NPI Number: 1417915315 PECOS PAC ID: 9335213297 Enrollment ID: I20140829000005 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Pei L Mulroy |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1568892115 PECOS PAC ID: 4284855065 Enrollment ID: I20141020001554 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Leejoe K Pallickal |
|---|---|
| Provider Type | Practitioner - Critical Care (intensivists) |
| Provider Identifiers | NPI Number: 1346402054 PECOS PAC ID: 2365598810 Enrollment ID: I20141114001444 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Larry Chee Chan |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1215259221 PECOS PAC ID: 3476775917 Enrollment ID: I20141118000023 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Rebecca H Young |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1740576230 PECOS PAC ID: 1052533460 Enrollment ID: I20141118002690 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Sophia S Hsu-zic |
|---|---|
| Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
| Provider Identifiers | NPI Number: 1447652839 PECOS PAC ID: 9830412212 Enrollment ID: I20141217000581 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Tony K Tseng |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1558523670 PECOS PAC ID: 6901920479 Enrollment ID: I20150102001126 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Daniel Kim |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1174801344 PECOS PAC ID: 6305164039 Enrollment ID: I20150409001015 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Jacqueline A Eubany |
|---|---|
| Provider Type | Practitioner - Cardiac Electrophysiology |
| Provider Identifiers | NPI Number: 1912986944 PECOS PAC ID: 6204882277 Enrollment ID: I20150428000723 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Judy M Choi |
|---|---|
| Provider Type | Practitioner - Urology |
| Provider Identifiers | NPI Number: 1386974483 PECOS PAC ID: 1658692850 Enrollment ID: I20150529002299 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Kaushik Ivaturi |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1669733275 PECOS PAC ID: 7214241900 Enrollment ID: I20150810001139 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Matthew J Reed |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1225356678 PECOS PAC ID: 1759696255 Enrollment ID: I20150812008759 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Samir Samarany |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1134379126 PECOS PAC ID: 9335312040 Enrollment ID: I20150813009864 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | David Filsoof |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1861686354 PECOS PAC ID: 2365698081 Enrollment ID: I20150813010221 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Zubin Udwadia |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1922364967 PECOS PAC ID: 7618282047 Enrollment ID: I20150814012690 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Renee M Garcia |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1699033738 PECOS PAC ID: 4587979620 Enrollment ID: I20150818005243 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Cory Michael Hugen |
|---|---|
| Provider Type | Practitioner - Urology |
| Provider Identifiers | NPI Number: 1184884280 PECOS PAC ID: 2961724349 Enrollment ID: I20150903001217 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Yasaman Mohtasebi |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1962687889 PECOS PAC ID: 3870630908 Enrollment ID: I20150914002849 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Dalia Ibrahim-abdelaziz |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1356502116 PECOS PAC ID: 2961709092 Enrollment ID: I20160404002332 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Roshan M Patel |
|---|---|
| Provider Type | Practitioner - Urology |
| Provider Identifiers | NPI Number: 1760774491 PECOS PAC ID: 2466684337 Enrollment ID: I20160415001491 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Melinda L Yambot-calderon |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1841653789 PECOS PAC ID: 0547569717 Enrollment ID: I20160422001404 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Tyler S Dejong |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1033537493 PECOS PAC ID: 9234436353 Enrollment ID: I20160513001682 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Lung-ching Lee |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1023339371 PECOS PAC ID: 5294972196 Enrollment ID: I20160523001836 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Edna A Yarashevich |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1972909968 PECOS PAC ID: 7618268426 Enrollment ID: I20160627001113 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Jennifer M Vicente |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1235522483 PECOS PAC ID: 2264724749 Enrollment ID: I20160630002016 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Lauren M Eisenberg |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1275994451 PECOS PAC ID: 1759673577 Enrollment ID: I20160714000655 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Zar C Chan |
|---|---|
| Provider Type | Practitioner - Nephrology |
| Provider Identifiers | NPI Number: 1417243890 PECOS PAC ID: 3375845860 Enrollment ID: I20161003000712 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Faysal A Yafi |
|---|---|
| Provider Type | Practitioner - Urology |
| Provider Identifiers | NPI Number: 1285854927 PECOS PAC ID: 3173745569 Enrollment ID: I20161014001229 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Geoffrey Konye |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1730504416 PECOS PAC ID: 0547548216 Enrollment ID: I20161031002485 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Mohammad Anas Hajjar |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1235350893 PECOS PAC ID: 3476640244 Enrollment ID: I20161123000726 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Darlene Mulyanto-mong |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1255873717 PECOS PAC ID: 9335420710 Enrollment ID: I20161222000854 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Marcus Ottochian |
|---|---|
| Provider Type | Practitioner - Critical Care (intensivists) |
| Provider Identifiers | NPI Number: 1952614307 PECOS PAC ID: 5193002574 Enrollment ID: I20170512001128 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Suraj P Rasania |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1245501899 PECOS PAC ID: 5890947766 Enrollment ID: I20170524002329 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Julian Jung Hee Choi |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1730506395 PECOS PAC ID: 3476822925 Enrollment ID: I20170627001781 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Yuichi E Yanami |
|---|---|
| Provider Type | Practitioner - Hospice/palliative Care |
| Provider Identifiers | NPI Number: 1265729339 PECOS PAC ID: 9931478120 Enrollment ID: I20170630002461 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Mehrdad Saliminejad |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1891934832 PECOS PAC ID: 0941453294 Enrollment ID: I20170822001496 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Sudhir Kapoor |
|---|---|
| Provider Type | Practitioner - Critical Care (intensivists) |
| Provider Identifiers | NPI Number: 1013073824 PECOS PAC ID: 9234233198 Enrollment ID: I20170911001381 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Ronald Frank Wolf |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1649369935 PECOS PAC ID: 3678667250 Enrollment ID: I20170925001058 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Shari-lynne Schroeder |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1710393673 PECOS PAC ID: 3971861154 Enrollment ID: I20171215001729 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Chioma Onyejekwe |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1548701535 PECOS PAC ID: 8628272556 Enrollment ID: I20180213001716 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Rishi Talwar |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1699184184 PECOS PAC ID: 3971863770 Enrollment ID: I20180215000664 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Alejren Tandoc Guevarra |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1457859399 PECOS PAC ID: 6103188164 Enrollment ID: I20180403000885 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Iris Partovi |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1104019462 PECOS PAC ID: 5597959627 Enrollment ID: I20180706000842 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | John B Javien |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1740504356 PECOS PAC ID: 7113220245 Enrollment ID: I20180712003193 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Mark M Archie |
|---|---|
| Provider Type | Practitioner - Vascular Surgery |
| Provider Identifiers | NPI Number: 1033553383 PECOS PAC ID: 2264789981 Enrollment ID: I20180725003199 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Daniel Jacob Cwikla |
|---|---|
| Provider Type | Practitioner - Urology |
| Provider Identifiers | NPI Number: 1205278603 PECOS PAC ID: 8921316126 Enrollment ID: I20180808001420 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Peyman Naji |
|---|---|
| Provider Type | Practitioner - Interventional Cardiology |
| Provider Identifiers | NPI Number: 1720215429 PECOS PAC ID: 7618126913 Enrollment ID: I20180808003514 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Anand Sandesara |
|---|---|
| Provider Type | Practitioner - Hospice/palliative Care |
| Provider Identifiers | NPI Number: 1174943336 PECOS PAC ID: 3476805623 Enrollment ID: I20181016002875 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Nina Michelle Bowens |
|---|---|
| Provider Type | Practitioner - Vascular Surgery |
| Provider Identifiers | NPI Number: 1962559039 PECOS PAC ID: 5799038139 Enrollment ID: I20181115001598 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Richard D Hernandez |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1275983124 PECOS PAC ID: 4880938117 Enrollment ID: I20181127003112 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Mary Lynn Seiersen |
|---|---|
| Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
| Provider Identifiers | NPI Number: 1538282983 PECOS PAC ID: 4284978867 Enrollment ID: I20181208000405 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Chau Nguyen Phung |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1245717966 PECOS PAC ID: 1052659166 Enrollment ID: I20190215000925 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Ann Kuhlman Williamson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1801316765 PECOS PAC ID: 9133468580 Enrollment ID: I20190228002092 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Monina Distor-castro |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1528379690 PECOS PAC ID: 1951644111 Enrollment ID: I20190510001133 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Wali Abawi |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1104362268 PECOS PAC ID: 7911230925 Enrollment ID: I20190606001069 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Shuchi Parikh |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1255899605 PECOS PAC ID: 8820321375 Enrollment ID: I20190614001868 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Sindalisa Hean |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1235559436 PECOS PAC ID: 2668706714 Enrollment ID: I20190625000515 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Babak Gachpaz |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1245502400 PECOS PAC ID: 0547559924 Enrollment ID: I20190628002945 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Nolan S Desa |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1245673896 PECOS PAC ID: 8426349937 Enrollment ID: I20190715002821 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Meena M Archie |
|---|---|
| Provider Type | Practitioner - Vascular Surgery |
| Provider Identifiers | NPI Number: 1588083646 PECOS PAC ID: 0840555256 Enrollment ID: I20190726002358 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Ravi K Solanki |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1164883112 PECOS PAC ID: 8729315387 Enrollment ID: I20190806001885 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Emma Caroline Duncan |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1902268394 PECOS PAC ID: 7911294988 Enrollment ID: I20190813003118 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Fazeel Shah |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1780046375 PECOS PAC ID: 8426386228 Enrollment ID: I20190816002750 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Rajveer Joea |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1841653672 PECOS PAC ID: 6406120526 Enrollment ID: I20190816002981 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Michelle Crespo |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1669828067 PECOS PAC ID: 6507194388 Enrollment ID: I20190819002322 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Wisam Majed Khader |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1841651767 PECOS PAC ID: 0749518488 Enrollment ID: I20190820001388 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Eric Q Trieu |
|---|---|
| Provider Type | Practitioner - Hospice/palliative Care |
| Provider Identifiers | NPI Number: 1124439047 PECOS PAC ID: 9133477144 Enrollment ID: I20190821002116 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Vishal I Patel |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1326493438 PECOS PAC ID: 3173853082 Enrollment ID: I20190919000424 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Catherine Peony Khoo |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1316309354 PECOS PAC ID: 2769739499 Enrollment ID: I20190925003757 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Kevin Huynh |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1851952030 PECOS PAC ID: 5991037046 Enrollment ID: I20191023001230 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Laura M Quigg |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1063784627 PECOS PAC ID: 6507028768 Enrollment ID: I20191024002996 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Larisa Garbar |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1811906753 PECOS PAC ID: 5193626158 Enrollment ID: I20191030001738 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Pengbo Jiang |
|---|---|
| Provider Type | Practitioner - Urology |
| Provider Identifiers | NPI Number: 1699185603 PECOS PAC ID: 5092088005 Enrollment ID: I20191108002745 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Julius A Musenze |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1144675315 PECOS PAC ID: 7810329729 Enrollment ID: I20191114002510 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Sanam M Pournaki |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1447607551 PECOS PAC ID: 5991099889 Enrollment ID: I20191204000323 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Cecile K Kokozian |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1336499342 PECOS PAC ID: 8628404977 Enrollment ID: I20200204001620 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Albert J Shin |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1558909705 PECOS PAC ID: 1153757273 Enrollment ID: I20200210001922 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Carmen Jean Asesor |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1770097909 PECOS PAC ID: 7618306366 Enrollment ID: I20200401002391 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Amit N Parikh |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1982066734 PECOS PAC ID: 8022302546 Enrollment ID: I20200608001060 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Kara Lauren De Winter |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1376989392 PECOS PAC ID: 9537303458 Enrollment ID: I20200708000357 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Edgar Guzman-suarez |
|---|---|
| Provider Type | Practitioner - Critical Care (intensivists) |
| Provider Identifiers | NPI Number: 1235526427 PECOS PAC ID: 7416227301 Enrollment ID: I20200731000838 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Sarah Fihn |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1215566922 PECOS PAC ID: 1759709223 Enrollment ID: I20200915002543 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Ali Varasteh |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1962927475 PECOS PAC ID: 6709205966 Enrollment ID: I20201007003077 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Ghazal Kooshk Jalali |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1154843571 PECOS PAC ID: 2466722103 Enrollment ID: I20201028003046 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Da Som Choi |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1407484058 PECOS PAC ID: 5294153730 Enrollment ID: I20210121002728 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Tim Nguyen |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1033721923 PECOS PAC ID: 9335554492 Enrollment ID: I20210223001572 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Ana Maria Cajigas De Jesus |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1801497706 PECOS PAC ID: 3173939733 Enrollment ID: I20210304002310 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Mary Joy Perez Floresca |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1174114078 PECOS PAC ID: 1153738547 Enrollment ID: I20210331002627 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | David W Barham |
|---|---|
| Provider Type | Practitioner - Urology |
| Provider Identifiers | NPI Number: 1639526718 PECOS PAC ID: 8022427814 Enrollment ID: I20210506003048 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Janine Marie Balasbas |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1982285052 PECOS PAC ID: 6002215126 Enrollment ID: I20210521002222 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Mruga Nanavati Morris |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1649701731 PECOS PAC ID: 1153693593 Enrollment ID: I20210617002060 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | David Andrew Sack |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1467657882 PECOS PAC ID: 8628478252 Enrollment ID: I20210617002742 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Henrietta C Nwaibe |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1508306176 PECOS PAC ID: 5991107708 Enrollment ID: I20210715001157 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Julie Ann Oates |
|---|---|
| Provider Type | Practitioner - Certified Nurse Midwife (cnm) |
| Provider Identifiers | NPI Number: 1912538166 PECOS PAC ID: 9436552825 Enrollment ID: I20210722001932 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Christina Noelle Arcuri |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1558855403 PECOS PAC ID: 2264835149 Enrollment ID: I20210729002892 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Seiya Tokunaga |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1629572334 PECOS PAC ID: 6901200377 Enrollment ID: I20210806000891 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Elechi M Egeonuigwe |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1952901969 PECOS PAC ID: 3678970605 Enrollment ID: I20210917001899 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Hamid Modarres Mousavi Behbahan |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1285123778 PECOS PAC ID: 5799020038 Enrollment ID: I20210921001317 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Madlena Nalbandian |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1982108015 PECOS PAC ID: 0042617847 Enrollment ID: I20210921003178 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Sohrab Naushad Ali |
|---|---|
| Provider Type | Practitioner - Urology |
| Provider Identifiers | NPI Number: 1851976260 PECOS PAC ID: 1951708643 Enrollment ID: I20210922003413 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Saman Setareh-shenas |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1194111799 PECOS PAC ID: 6204234776 Enrollment ID: I20211013003200 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Nima Fatehi |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1699260265 PECOS PAC ID: 3779981121 Enrollment ID: I20211015000005 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Mamak Eatesam |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1407139314 PECOS PAC ID: 5092033571 Enrollment ID: I20211015001685 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Sandra Yu Kim |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1306355698 PECOS PAC ID: 9335538545 Enrollment ID: I20211109002992 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Teal Renee Curry |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1659977221 PECOS PAC ID: 4486043163 Enrollment ID: I20211118001380 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Princess Marie April T Denolo |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1447913603 PECOS PAC ID: 0143610790 Enrollment ID: I20211214001554 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Karen Ogboro |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1649946385 PECOS PAC ID: 5092106237 Enrollment ID: I20211227000692 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Christine Uy Titensky |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1003416363 PECOS PAC ID: 6709278799 Enrollment ID: I20220125002412 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Katrina E Buxbaum |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1710266242 PECOS PAC ID: 7012309842 Enrollment ID: I20220127002184 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Thomas Decato |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1043535370 PECOS PAC ID: 1456582139 Enrollment ID: I20220201000642 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Ivy Lee De Quiros |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1831442763 PECOS PAC ID: 4284027426 Enrollment ID: I20220210000854 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Akhil K Das |
|---|---|
| Provider Type | Practitioner - Urology |
| Provider Identifiers | NPI Number: 1053310821 PECOS PAC ID: 7113818790 Enrollment ID: I20220217000227 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Nathan Yee |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1982021424 PECOS PAC ID: 7012232937 Enrollment ID: I20220221001701 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Elizabeth Whitham |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1417480625 PECOS PAC ID: 4981976834 Enrollment ID: I20220224002571 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Dalia A Cadena |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1548885890 PECOS PAC ID: 8729473608 Enrollment ID: I20220310001929 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | John Lee |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1750879755 PECOS PAC ID: 5193060358 Enrollment ID: I20220426000790 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Zachary Edward Tano |
|---|---|
| Provider Type | Practitioner - Urology |
| Provider Identifiers | NPI Number: 1275971459 PECOS PAC ID: 0143607093 Enrollment ID: I20220513001579 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Kym Ann Lagafuaina |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1609306232 PECOS PAC ID: 6709147390 Enrollment ID: I20220519001880 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Sylvia Cyntia Guthrie |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1861146045 PECOS PAC ID: 9537546999 Enrollment ID: I20220524002960 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Veronica Zoleta |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1992446868 PECOS PAC ID: 7113305426 Enrollment ID: I20220527000538 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Cameron S Sikavi |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1114303302 PECOS PAC ID: 6103161732 Enrollment ID: I20220601000668 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Nisha Patel |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1083369151 PECOS PAC ID: 4688053168 Enrollment ID: I20220614002754 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Jacob Richard Basilius |
|---|---|
| Provider Type | Practitioner - Urology |
| Provider Identifiers | NPI Number: 1043741911 PECOS PAC ID: 4284988940 Enrollment ID: I20220624000379 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Aida Marie Souleiman |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1205427150 PECOS PAC ID: 6507245263 Enrollment ID: I20220627001780 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Adriana Westby Trent |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1518081942 PECOS PAC ID: 3072993294 Enrollment ID: I20220706002438 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Kelsey Goodman |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1790454833 PECOS PAC ID: 3678953551 Enrollment ID: I20220708003544 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Young Soon Yang |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1700387891 PECOS PAC ID: 4981085008 Enrollment ID: I20220721000597 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Jinah K Choi |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1700241387 PECOS PAC ID: 0840672697 Enrollment ID: I20220727000387 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Sweta Chekuri |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1841584273 PECOS PAC ID: 5294957197 Enrollment ID: I20220803002786 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Kerry Lee Moseman |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1225597008 PECOS PAC ID: 6901289123 Enrollment ID: I20220819001796 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Vatche Satamian |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1982163044 PECOS PAC ID: 5496163271 Enrollment ID: I20220822002639 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Marian M Varda |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1861951741 PECOS PAC ID: 6002291739 Enrollment ID: I20220916001669 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Mariam Zakher |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1396302071 PECOS PAC ID: 9830574094 Enrollment ID: I20220923002367 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Prince Bedford Acquah |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1902415623 PECOS PAC ID: 0143606293 Enrollment ID: I20220927003791 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Olivia Hui-chiun Chang |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1881936862 PECOS PAC ID: 2264758762 Enrollment ID: I20221017003168 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Debby Chung |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1235608316 PECOS PAC ID: 8325415391 Enrollment ID: I20221103001598 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Wendy Uyen Vu |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1629598529 PECOS PAC ID: 7911375159 Enrollment ID: I20221121000391 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Rajesh Garg |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1609863190 PECOS PAC ID: 2860486453 Enrollment ID: I20221123001222 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Lucetta Waiying Chiu |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1114648227 PECOS PAC ID: 9032589775 Enrollment ID: I20221221001803 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Kristina Renee Vartanian |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1609599562 PECOS PAC ID: 6002286408 Enrollment ID: I20221229001132 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Danielle Marie Villatoro |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1023560885 PECOS PAC ID: 2860823812 Enrollment ID: I20230130001368 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Nimisha Thakkar |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1386396943 PECOS PAC ID: 3577937846 Enrollment ID: I20230328002218 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Monika Shenouda |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1508489816 PECOS PAC ID: 7719352111 Enrollment ID: I20230418001162 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Kevin Charles |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1649616558 PECOS PAC ID: 0042519704 Enrollment ID: I20230510000611 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Khashayar Nemovi |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1225667991 PECOS PAC ID: 9830557487 Enrollment ID: I20230614001960 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Christianna Finn |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1417661489 PECOS PAC ID: 3779941141 Enrollment ID: I20230619001619 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Miguel Arellano |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1295460806 PECOS PAC ID: 4284092966 Enrollment ID: I20230628001990 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Hasan Mirza |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1861013153 PECOS PAC ID: 3678932118 Enrollment ID: I20230630002856 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Hannaneh Saadaeijahromi |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1962030973 PECOS PAC ID: 3577923317 Enrollment ID: I20230712002040 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Rithika Ramakrishnan |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1316476484 PECOS PAC ID: 5092083048 Enrollment ID: I20230727001014 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Jennifer Sheila Ponce Demaree |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1518650605 PECOS PAC ID: 9537520101 Enrollment ID: I20230728001578 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Ruby Elaine Calalo |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1043915440 PECOS PAC ID: 1658639315 Enrollment ID: I20230809003528 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Brandon Cole Schmeits |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1659909174 PECOS PAC ID: 8224453113 Enrollment ID: I20230908001725 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Bruce Ming Gao |
|---|---|
| Provider Type | Practitioner - Urology |
| Provider Identifiers | NPI Number: 1750065884 PECOS PAC ID: 3173977428 Enrollment ID: I20230920004171 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Samit Bhatheja |
|---|---|
| Provider Type | Practitioner - Interventional Cardiology |
| Provider Identifiers | NPI Number: 1871818385 PECOS PAC ID: 6002164274 Enrollment ID: I20230921002106 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Katharine E Arce |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1780674069 PECOS PAC ID: 2062867492 Enrollment ID: I20231004003820 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Amanda Dupre |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1467913194 PECOS PAC ID: 2466832118 Enrollment ID: I20231018003187 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Jennifer Ngo |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1174300875 PECOS PAC ID: 8325494313 Enrollment ID: I20231027000315 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Jessie Jesusyesenia Ortiz |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1174803332 PECOS PAC ID: 6002262953 Enrollment ID: I20231027003090 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Ibrahim Elali |
|---|---|
| Provider Type | Practitioner - Nephrology |
| Provider Identifiers | NPI Number: 1932141421 PECOS PAC ID: 0648276733 Enrollment ID: I20231115003209 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Michele Nelson-chung |
|---|---|
| Provider Type | Practitioner - Marriage And Family Therapist |
| Provider Identifiers | NPI Number: 1548704612 PECOS PAC ID: 1557712619 Enrollment ID: I20240112002796 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Rebekah Dorothy Ruther |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1528757325 PECOS PAC ID: 2365894003 Enrollment ID: I20240118002921 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Judy Young Lee |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1528763968 PECOS PAC ID: 1355786849 Enrollment ID: I20240223001744 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Jessica Nicole Sota |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1790464634 PECOS PAC ID: 0547606162 Enrollment ID: I20240306000588 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
| Provider Name | Chantell Strong |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1053817783 PECOS PAC ID: 9638426000 Enrollment ID: I20240315001092 |
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
News Archive
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Ten percent of firearm injury survivors will be readmitted to the hospital for further treatment within 90 days of their original injuries.
› Verified 3 days ago
Lakewood Medical Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4318 South St, Lakewood, CA 90712 Phone: 562-788-7574 Fax: 562-788-7650 | |
Prohealth Partners, A Medical Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5750 Downey Ave Ste 202, Lakewood, CA 90712 Phone: 562-634-4939 Fax: 562-634-5809 | |
Zuberi Medical Group Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3514 E South St, Lakewood, CA 90712 Phone: 310-908-9338 Fax: 562-808-2145 | |
Prohealth Partners, A Medical Group, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3650 South St, Suite 210, Lakewood, CA 90712 Phone: 562-630-0910 Fax: 562-630-4877 | |
Jesse J Licuanan Md A Medical Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3300 E South St, Suite 205, Lakewood, CA 90805 Phone: 562-531-0377 Fax: 562-531-1724 | |
Planned Parenthood Los Angeles-lakewood Center Basic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5519 Del Amo Blvd, Lakewood, CA 90713 Phone: 213-284-3126 Fax: 562-867-6846 |